Please check the following:
- {{x.value}}
FREE membership
FREE membership
Join Intelligent Investor today
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
Please enter the 5 digit verification code sent to "{{user.DayPhone}}" Change number
We cannot send you a verification code via SMS to "{{user.DayPhone}}" Change number
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
Please enter your mobile number and press send to receive a text message with a verification code.
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
Thank you
We have sent you an email with the details of your registration.
Purchase order
Sign up
Log in
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Log in
Upgrade Today
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
{{eventFunction.Name}}
{{eventFunction.EventTypeName}}
{{eventFunction.StartDate}}
{{eventFunction.EventTimings}}
{{eventFunction.VenueName}}
{{ t.Cost === 0 ? "FREE" : "$" + t.Cost.toFixed(2) }}
Quantity *
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
Congratulations!
You now have free access to InvestSMART, we look forward to helping you on your financial journey.
You now have access to Free Eureka Report Insights, We look forward to helping you on your financial journey.
You now have access to Intelligent Investor Free Insights. We look forward to helping you build a market beating stock portfolio.
Looking for more…
Intelligent Investor Membership
15-day Free Trial
- Indepth analysis of ASX listed shares
- BUY, Hold and Sell Recommendations
- Ideas Lab
- Special Reports
No thanks
Looking for more…
Eureka Report Membership
15-day Free Trial
- Alan Kohler’s Weekend Briefing
- Interviews with CEO’s & top influencers
- Money Cafe and Talking Finance
- Super Advice and Q&A with Ask Alan
No thanks
Bio-Gene Technology Ltd (ASX: BGT) - Share Price and Research
- Current share price for BGT : $0.075
Bio-Gene Technology Ltd (BGT), an ASX-listed company, is to pursue the development and commercialisation of insecticide products. Bio-Gene is seeking to commercialise Qcide and Flavocide products via partners as insecticide formulations for use in a range of target markets. Bio-Gene is an Australian agtech company enabling the next generation of novel insecticides. Bio-Gene's novel platform technology is based on a naturally occurring class of chemicals known as beta-triketones.
BGT General Information +
| ASX Code | BGT |
| Website | http://www.Bio-gene.com.au |
| Industry/Sector | Fertilizers & Agricultural Chemicals |
| Market Cap ($M) | 15 |
| BGT Share Price | $0.075 |
| Day High | $0.000 |
| Day Low | $0.000 |
| Last Close | $0.075 |
| BGT Share Price Movement | - ( No change ) |
Prices as at 16:40, 23 Apr 2024
+Security prices are delayed by at least 20 minutes and are indicative only.
BGT Related Research
Bio-Gene Technology Ltd (BGT) Upcoming Dividends & Yields
There are no dividends for Bio-Gene Technology Ltd (BGT). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Bio-Gene Technology Ltd (BGT) Recent ASX Announcements
| Headline | Annoucement date/time+ | Price at announcement+ | Current price+ | Price 7D Avg | Gain/Loss |
|---|---|---|---|---|---|
| Appointment of CFO and Joint Company Secretary | 8 Apr 2024 9:55AM | $0.075 | $0.075 | $0.072 | fallen by 0% |
| Investor Webinar - FY24 Half Year Review | 5 Mar 2024 10:08AM | $0.038 | $0.075 | $0.072 | risen by 97.37% |
| Appendix 4D - Half Year Accounts - 31 December 2023 | 26 Feb 2024 9:45AM | $0.050 | $0.075 | $0.072 | risen by 50% |
- + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.
See all ASX announcements from Bio-Gene Technology Ltd (BGT) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.
BGT Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2023A | -$3.10 | -$1.90 | -2.60% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2022A | -$2.91 | -$1.90 | 8.60% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2021A | -$2.40 | -$1.80 | 8.00% | 0.00 | 0.00 | 0.00% | 0.0% |
BGT Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2021 A | 2022 A | 2023 A | 2021 A | 2022 A | 2023 A | 2021 A | 2022 A | 2023 A | ||
| Bio-Gene Technology (BGT) | $15M | -0.0263 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Nufarm (NUF) | $1,964M | -0.0764 | 0.0765 | 0.4132 | 15.9876 | 14.8512 | 10.5091 | 1.95% | 2.14% | 3.01% |
BGT Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 4.12 | 0.00 |
| Market | 0.40 | 15.10 | 1.10 | 1.04 |
| Sector | 1.59 | 15.10 | 1.01 | 0.33 |
BGT Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Peter May | Research & Development, Executive Director | 29 May 2015 |
| Mr Owen Timothy Grogan | Chief Executive Officer, Managing Director | 28 Aug 2023 |
| Mr Andrew Wallace Guthrie | Non-Executive Director | 26 Apr 2021 |
| Mr Alex Huong Soo Ding | Non-Executive Director | 12 May 2023 |
| Mr Christopher Mark Ramsey | Non-Executive Director | 12 May 2023 |
Bio-Gene Technology Ltd (BGT) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 23 Nov 2023 | GUTHRIE, Andrew | Issued | Indirect Shares | 120,000 | $0.084 | $10,080.000 |
| 23 Nov 2023 | DING, Alex | Issued | Indirect Shares | 4,761,904 | $0.084 | $399,999.940 |
| 23 Nov 2023 | GROGAN, Owen | Issued | Indirect Shares | 59,524 | $0.084 | $5,000.020 |
See all changes in directors' interest & trades for Bio-Gene Technology Ltd (BGT) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
BGT Management
| Name | Position |
|---|---|
| Rod Valencia | Chief Financial Officer, Company Secretary, and Investor Relations Officer |
| Edmond Tern | Chief Financial Officer,Joint Company Secretary |
| Roger McPherson | Company Secretary |
BGT Calendar of Events
| Date | Event |
|---|---|
| 04 March 2025 | Report (Interim) |
| 24 February 2025 | Report (Interim) |
| 29 July 2024 | Report (Annual) |
| 29 July 2024 | Report (Prelim) |
FAQs about Bio-Gene Technology Ltd (BGT)
What is the current share price of Bio-Gene Technology Ltd (BGT)?
Bio-Gene Technology Ltd's (BGT) current share price is $0.08. This constitutes a price movement of 4.17% when compared to the share price 7 days ago and is -42.31% below BGT's 12-month high of $0.13 per share. Prices are delayed by at least 20 minutes.
What is the share price movement for Bio-Gene Technology Ltd (BGT)?
Relative to the previous close share price of $0.08, Bio-Gene Technology Ltd's (BGT) current share price of $0.08 constitutes a movement of or 0%. Bio-Gene Technology Ltd's (BGT) share price movement is 4.17% when compared to 7 days ago and is -42.31% below BGT's 52-week high of $0.13.
What is the 52-week high share price for Bio-Gene Technology Ltd (BGT)?
Bio-Gene Technology Ltd's (BGT) 52-week high is $0.13 which was reached on 5 May 2023. Relative to this, BGT's current share price of $0.08 constitutes a -$0.06 or -42.31% drop since that high of $0.13 per BGT share.
What is the 52-week low share price for Bio-Gene Technology Ltd (BGT)?
Bio-Gene Technology Ltd's (BGT) 52-week low is $0.04 which was reached on 4 Mar 2024. Relative to this, BGT's current share price of $0.08 constitutes a $0.04 or 97.37% gain since that low of $0.04 per BGT share.
What is the daily average trading volume for Bio-Gene Technology Ltd (BGT)?
Over the last 12 months, Bio-Gene Technology Ltd (BGT) has a daily average trading volume of 66,169 BGT shares per day.
What is the dividend yield for Bio-Gene Technology Ltd (BGT)?
Bio-Gene Technology Ltd (BGT) has a current dividend yield of n/a this year. Last year's dividend yield was 0%. The dividend yield for BGT is a ratio that tells you the percentage of Bio-Gene Technology Ltd's (BGT) share price that it pays out in dividends each year.
When does Bio-Gene Technology Ltd (BGT) release its next Annual Report?
Bio-Gene Technology Ltd (BGT) will release its next Annual Report on 29 July 2024. Bio-Gene Technology Ltd's (BGT) last annual report was released on 31 Jul 2023. Click here to view Bio-Gene Technology Ltd's (BGT) last annual report.
In which sector is Bio-Gene Technology Ltd (BGT) classified?
Bio-Gene Technology Ltd (BGT) is classified as Materials. Other companies in this sector include BHP Group Limited (BHP), Fortescue Ltd (FMG), Newmont Corporation (NEM), and Rio Tinto Limited (RIO).
What is the price-to-earnings (P/E) ratio for Bio-Gene Technology Ltd (BGT)?
The price-to-earnings (P/E) ratio for Bio-Gene Technology Ltd (BGT) is 0. The price-to-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of Bio-Gene Technology Ltd's (BGT) share price to its earnings per BGT share.
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
